European Union - English - EMA (European Medicines Agency)

helsinn birex pharmaceuticals ltd. - palonosetron hydrochloride - vomiting; cancer - antiemetics and antinauseants, , serotonin (5ht3) antagonists - aloxi is indicated in adults for:the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy,the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.aloxi is indicated in paediatric patients 1 month of age and older for:the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

Israel - English - Ministry of Health

rafa laboratories ltd - palonosetron as hydrochloride - solution for injection - palonosetron as hydrochloride 0.25 mg/vial - palonosetron - palonosetron - paloxi is indicated in adults and in paediatric patients 1 month of age and older for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

Israel - English - Ministry of Health

rafa laboratories ltd - palonosetron as hydrochloride - solution for injection - palonosetron as hydrochloride 0.25 mg/vial - palonosetron - palonosetron - paloxi is indicated in adults and in paediatric patients 1 month of age and older for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - palonosetron hydrochloride - solution for injection - 250 microgram - serotonin (5ht3) antagonists

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - palonosetron hydrochloride - 250 microgram - serotonin (5ht3) antagonists

European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - palonosetron - vomiting; nausea; cancer - antiemetics and antinauseants, - palonosetron accord is indicated in adults for:the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy,the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.palonosetron accord is indicated in paediatric patients 1 month of age and older for:the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

European Union - English - EMA (European Medicines Agency)

pfizer europe ma eeig - palonosetron hydrochloride - nausea; vomiting; cancer - antiemetics and antinauseants, - palonosetron hospira is indicated in adults for:the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy;the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.palonosetron hospira is indicated in paediatric patients 1 month of age and older for:the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord healthcare ltd - palonosetron hydrochloride - solution for injection - 50microgram/1ml

Malta - English - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - palonosetron hydrochloride - solution for injection - palonosetron hydrochloride 50 µg - antiemetics and antinauseants

Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - palonosetron hydrochloride - solution for injection - palonosetron hydrochloride 50 µg/ml - antiemetics and antinauseants